Archive

Ivermectin repurposed for covid-19 – a cheap drug with a big effect

Written by | 7 Dec 2020

Numerous clinical trials with ivermectin in covid-19 have shown consistent, large magnitude improvements in clinical outcomes that are little short of spectacular but getting the world to listen […]

Vaccines – getting the message across

Written by | 28 Nov 2020

Knowing that your GP or pharmacist has had the vaccine can be deeply reassuring, according to Gary Finnegan, health journalist and Editor of Vaccines Today. When communicating about […]

Vaccine confidence and hesitancy

Written by | 27 Nov 2020

Understanding the three Cs of vaccine hesitancy could be the key to ensuring effective uptake of covid-19 vaccines, according to Gary Finnegan, health journalist and Editor of Vaccines […]

Vaccines: where are we now?

Written by | 26 Nov 2020

As planning for a mass covid vaccination campaign gets started, an understanding of vaccines and the factors that drive vaccine confidence will be essential for success. The past […]

Deficient vitamin D status associated with increased COVID-19 risk

Written by | 22 Nov 2020

Researchers from a retrospective study have reported an association between vitamin D deficiency and an increase in the risk of becoming infected with the coronavirus. The findings were […]

Pandemic critical care drug requirements – lessons learned

Written by | 18 Nov 2020

Pharmacist Anita Hogg explains how well Medicines Optimisation Innovation Centre (MOIC) model to estimate the critical care drug requirements during the covid-19 pandemic worked and the lessons learned […]

Estimating pandemic critical care drug requirements

Written by | 17 Nov 2020

Pharmacist Anita Hogg explains how the Medicines Optimisation Innovation Centre (MOIC) in Belfast developed and applied a model to estimate the critical care drug requirements during the covid-19 […]

The MOIC and pandemic critical care drug requirements

Written by | 16 Nov 2020

Pharmacist Anita Hogg explains the work of the Medicines Optimisation Innovation Centre (MOIC) in Belfast and how the Centre helped to ensure reliable provision of critical care drugs […]

Stronger antibody response to more severe disease

Written by | 15 Nov 2020

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease, […]

Most psoriasis patients taking immunosuppressants survive COVID-19

Written by | 14 Nov 2020

Patients with psoriasis who are taking drugs that affect their immune system have high rates of survival from COVID-19. According to the first findings from a global registry […]

Practice pharmacy services during the covid pandemic and in the future

Written by | 4 Nov 2020

Practice pharmacists were able to adjust and simplify drug treatment to ensure continued effective treatment during the covid pandemic – and could do more of this type of […]

Coronavirus tests – findings amongst laboratory staff and implications for herd immunity

Written by | 28 Oct 2020

Testing of hospital laboratory staff for antibodies to covid-19 revealed some interesting findings and led to questions about herd immunity. At the beginning of the covid pandemic Mr […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.